This inventor holds 1 USPTO granted patent. Top assignees: The Children's Hospital of Philadelphia, University System of Maryland. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2023
Title: Masahiro Iwamoto: Innovator in Bone Growth Manipulation
Introduction
Masahiro Iwamoto is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of orthopedic medicine through his innovative research and inventions. His work focuses on addressing critical issues related to bone growth and development.
Latest Patents
Iwamoto holds a patent for "Selective RARγ ligand-loaded nanoparticles for manipulation of targeted bone growth." This invention relates to compositions and methods that form part of a pharmacotherapeutic strategy targeting the endochondral ossification process in a selective and site-specific manner. The invention addresses various orthopedic pathologies caused by dysregulation of endochondral ossification, such as trauma to the bone growth plate, which can lead to serious imbalances in bone growth. The patented technology provides RARγ agonist and antagonist nanoparticle compositions that can treat abnormal endochondral ossification and bone growth, delivering robust local therapeutic control with long-lasting effects.
Career Highlights
Throughout his career, Masahiro Iwamoto has worked with esteemed institutions, including the University System of Maryland and The Children's Hospital of Philadelphia. His research has significantly advanced the understanding of bone growth and its manipulation through innovative therapeutic strategies.
Collaborations
Iwamoto has collaborated with various professionals in his field, including Michael Chorny, to further enhance the impact of his research and inventions.
Conclusion
Masahiro Iwamoto's contributions to orthopedic medicine through his innovative patent demonstrate his commitment to improving treatment options for bone growth disorders. His work continues to pave the way for advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile